Related Experiment Video
Updated: Aug 2, 2025

06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.4K
Postcancer treatment support programme: an evaluation
Charlotte Murray1, Jenny Makinson2, Lauren Brown1
1Health Psychology, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
BMJ Supportive & Palliative Care
|April 18, 2023
Summary
Participation in the "Where Now?" programme significantly improved self-efficacy and quality of life for cancer survivors. It also reduced cancer worry, though healthy eating did not change.
Area of Science:
- Oncology
- Psychology
- Health Behavior
Background:
- Growing population of cancer survivors requires effective post-treatment support.
- Supportive interventions are crucial for managing survivorship challenges.
- The Maggie's 'Where Now?' programme offers post-cancer support.
Purpose of the Study:
- To evaluate the impact of the 'Where Now?' programme on cancer survivors.
- To assess changes in healthy eating, quality of life, self-efficacy, and cancer worry.
- To identify behaviour change techniques used in the programme.
Main Methods:
- A pre-post study design was employed.
- 88 cancer survivors participated in the 7-week 'Where Now?' programme.
- Participants self-reported on diet, activity, quality of life, self-efficacy, and cancer worry before and after the programme.
Main Results:
- Significant improvements were observed in general self-efficacy (p=0.01) and physical activity self-efficacy (p<0.01).
- Quality of life (p<0.01) and cancer worry (p=0.04) also showed significant positive changes.
- No significant changes were found in healthy eating habits (p=0.23).
Conclusions:
- The 'Where Now?' programme positively impacts key psychological outcomes for individuals living beyond cancer.
- Techniques like instruction, problem-solving encouragement, and goal setting were prominent.
- The programme demonstrates effectiveness in supporting cancer survivors' psychological well-being.
Related Concept Videos
Cancer Survival Analysis
406
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
406
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Vaccines
456
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
456
Tumor Immunotherapy
596
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
596

